Davis Rea LTD. Has $4.50 Million Position in Danaher Co. (NYSE:DHR)

Davis Rea LTD. lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 1.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 16,167 shares of the conglomerate’s stock after selling 202 shares during the quarter. Danaher makes up approximately 2.0% of Davis Rea LTD.’s portfolio, making the stock its 16th largest holding. Davis Rea LTD.’s holdings in Danaher were worth $4,499,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Norden Group LLC acquired a new stake in shares of Danaher in the 1st quarter valued at $4,151,000. Advisor Resource Council acquired a new stake in shares of Danaher during the 1st quarter worth about $260,000. Veracity Capital LLC grew its stake in Danaher by 4.9% during the first quarter. Veracity Capital LLC now owns 1,490 shares of the conglomerate’s stock worth $372,000 after buying an additional 69 shares in the last quarter. FORVIS Wealth Advisors LLC lifted its position in shares of Danaher by 7.2% during the 1st quarter. FORVIS Wealth Advisors LLC now owns 10,369 shares of the conglomerate’s stock worth $2,589,000 after buying an additional 699 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC boosted its holdings in shares of Danaher by 44.5% during the 1st quarter. Ashton Thomas Private Wealth LLC now owns 4,970 shares of the conglomerate’s stock valued at $1,241,000 after acquiring an additional 1,530 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.1 %

Danaher stock opened at $242.64 on Thursday. The business has a fifty day moving average price of $267.83 and a 200-day moving average price of $260.42. The stock has a market capitalization of $179.72 billion, a price-to-earnings ratio of 41.07, a PEG ratio of 4.49 and a beta of 0.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. Danaher Co. has a 1-year low of $188.75 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.02 earnings per share. Equities research analysts forecast that Danaher Co. will post 7.59 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s payout ratio is 18.31%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on DHR shares. The Goldman Sachs Group boosted their price target on shares of Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 24th. Robert W. Baird cut their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a report on Thursday. Stifel Nicolaus lifted their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Finally, KeyCorp increased their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $287.16.

Insider Buying and Selling

In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.